RESI is the hot spot for the early-stage life science companies (Drugs, Devices, Diagnostics, and Digital Health, and raising Seed to Series B under $50M USD) to begin meeting investors and strategic partners who may eventually become a part of current or future capital raises.

Hybrid RESI San Francisco January (10-12th): (one day in-person, two-days virtual) The first day on the 10th will consist of in-person partnering, pitch sessions, investor-led panels, and workshops, followed by last two days of entirely virtual partnering. We are expecting 500+ global investors and strategic partners.

BIOTECanada members receive 50% off standard registration. Join our Tech Hub today! To obtain your discount code email us: shaely.williams@biotech.ca